Health care stocks were rising premarket Friday with the iShares Biotechnology ETF (IBB) up 0.9% and the Health Care Select Sector SPDR Fund (XLV) 0.3% higher recently.
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) said the US Food and Drug Administration approved Dupixent for the treatment of adult patients with bullous pemphigoid. Shares of Sanofi and Regeneron Pharmaceuticals were up 1% pre-bell.
Madrigal Pharmaceuticals (MDGL) shares were up nearly 2% after the company said it received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use for resmetirom to treat noncirrhotic metabolic dysfunction-associated steatohepatitis with moderate to advanced liver fibrosis.
Evolent Health (EVH) shares were nearly 2% higher after the company reiterated its Q2 and 2025 adjusted earnings before interest, taxes, depreciation and amortization guidance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.